MangoRx hits back at Eli Lilly's weight loss drug copycat claims

By Yahoo! Finance | Oct 22, 2024 at 10:39 AM EST

MangoRx has strongly denied Eli Lilly's claims of improper copying of weight-loss drugs and is prepared to defend itself. The FDA's decisions on drug shortages and compounders' rights are also discussed in relation to this ongoing legal dispute.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.